" class="no-js "lang="en-US"> Companies Archive - Page 102 of 145 - Medtech Alert
Sunday, October 26, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
1448 Results.

View Company

 Dyne Therapeutics | Pharmtech Focus

Dyne Therapeutics

View Company

 FluGen

FluGen, Inc.

View Company

 Naobios | Pharmtech Focus

Naobios

View Company

 International Longevity Centre-UK (ILC) | Pharmtech Focus

International Longevity Centre-UK (ILC)

View Company

 ResInnova Labs | Pharmtech Focus

ResInnova Labs

View Company

 Icahn School of Medicine at Mount Sinai | Pharmtech Focus

Icahn School of Medicine at Mount Sinai

View Company

 University of Cambridge | Pharmtech Focus

University of Cambridge

View Company

 Ascend Performance Materials | Pharmtech Focus

Ascend Performance Materials

View Company

 Oracle | Pharmtech Focus

Oracle

View Company

 Elevian | Pharmtech Focus

Elevian

Load More Results